Northern Trust’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.01M | Buy |
370,534
+40,607
| +12% | +$718K | ﹤0.01% | 2362 |
|
|
2025
Q4 | $6.17M | Sell |
329,927
-11,379
| -3% | -$189K | ﹤0.01% | 2350 |
|
|
2025
Q3 | $4.98M | Sell |
341,306
-10,919
| -3% | -$138K | ﹤0.01% | 2510 |
|
|
2025
Q2 | $3.89M | Buy |
352,225
+2,808
| +0.8% | +$27.3K | ﹤0.01% | 2606 |
|
|
2025
Q1 | $3.12M | Sell |
349,417
-40,563
| -10% | -$377K | ﹤0.01% | 2675 |
|
|
2024
Q4 | $3.67M | Buy |
389,980
+6,198
| +2% | +$56.4K | ﹤0.01% | 2693 |
|
|
2024
Q3 | $3.09M | Sell |
383,782
-81,185
| -17% | -$703K | ﹤0.01% | 2734 |
|
|
2024
Q2 | $3.94M | Sell |
464,967
-23,785
| -5% | -$215K | ﹤0.01% | 2523 |
|
|
2024
Q1 | $4.38M | Sell |
488,752
-33,184
| -6% | -$307K | ﹤0.01% | 2553 |
|
|
2023
Q4 | $5.87M | Sell |
521,936
-34,459
| -6% | -$347K | ﹤0.01% | 2400 |
|
|
2023
Q3 | $4.8M | Sell |
556,395
-61,113
| -10% | -$590K | ﹤0.01% | 2465 |
|
|
2023
Q2 | $6.39M | Sell |
617,508
-30,571
| -5% | -$338K | ﹤0.01% | 2377 |
|
|
2023
Q1 | $7.03M | Buy |
648,079
+11,674
| +2% | +$123K | ﹤0.01% | 2250 |
|
|
2022
Q4 | $7.14M | Buy |
636,405
+38,102
| +6% | +$400K | ﹤0.01% | 2237 |
|
|
2022
Q3 | $6.07M | Buy |
598,303
+3,069
| +0.5% | +$28.8K | ﹤0.01% | 2340 |
|
|
2022
Q2 | $5.39M | Buy |
595,234
+6,181
| +1% | +$57K | ﹤0.01% | 2461 |
|
|
2022
Q1 | $5.63M | Sell |
589,053
-25,308
| -4% | -$248K | ﹤0.01% | 2512 |
|
|
2021
Q4 | $6.79M | Buy |
614,361
+11,723
| +2% | +$102K | ﹤0.01% | 2511 |
|
|
2021
Q3 | $4.46M | Buy |
602,638
+41,705
| +7% | +$466K | ﹤0.01% | 2797 |
|
|
2021
Q2 | $8.14M | Buy |
560,933
+41,703
| +8% | +$783K | ﹤0.01% | 2518 |
|
|
2021
Q1 | $10.6M | Sell |
519,230
-19,462
| -4% | -$370K | ﹤0.01% | 2249 |
|
|
2020
Q4 | $9.57M | Sell |
538,692
-65,010
| -11% | -$1.17M | ﹤0.01% | 2274 |
|
|
2020
Q3 | $8.93M | Sell |
603,702
-29,626
| -5% | -$555K | ﹤0.01% | 2172 |
|
|
2020
Q2 | $13.3M | Buy |
633,328
+11,158
| +2% | +$287K | ﹤0.01% | 1924 |
|
|
2020
Q1 | $14.4M | Buy |
622,170
+50,594
| +9% | +$1.27M | ﹤0.01% | 1634 |
|
|
2019
Q4 | $14.8M | Sell |
571,576
-6,094
| -1% | -$118K | ﹤0.01% | 1929 |
|
|
2019
Q3 | $11.3M | Buy |
577,670
+24,041
| +4% | +$486K | ﹤0.01% | 2071 |
|
|
2019
Q2 | $9.04M | Buy |
553,629
+3,547
| +0.6% | +$71.9K | ﹤0.01% | 2217 |
|
|
2019
Q1 | $12.5M | Sell |
550,082
-714
| -0.1% | -$18.1K | ﹤0.01% | 2003 |
|
|
2018
Q4 | $14.1M | Buy |
550,796
+4,274
| +0.8% | +$115K | ﹤0.01% | 1848 |
|
|
2018
Q3 | $17.9M | Buy |
546,522
+11,238
| +2% | +$306K | ﹤0.01% | 1872 |
|
|
2018
Q2 | $12.1M | Buy |
535,284
+18,733
| +4% | +$445K | ﹤0.01% | 2142 |
|
|
2018
Q1 | $12.5M | Buy |
516,551
+4,509
| +0.9% | +$124K | ﹤0.01% | 2014 |
|
|
2017
Q4 | $14.3M | Sell |
512,042
-14,253
| -3% | -$422K | ﹤0.01% | 1955 |
|
|
2017
Q3 | $18M | Sell |
526,295
-3,754
| -0.7% | -$123K | ﹤0.01% | 1782 |
|
|
2017
Q2 | $21.1M | Buy |
530,049
+30,611
| +6% | +$1.18M | 0.01% | 1630 |
|
|
2017
Q1 | $18.4M | Buy |
499,438
+25,884
| +5% | +$827K | 0.01% | 1685 |
|
|
2016
Q4 | $15.1M | Buy |
473,554
+48,560
| +11% | +$1.51M | ﹤0.01% | 1811 |
|
|
2016
Q3 | $15.4M | Buy |
424,994
+274,760
| +183% | +$7.65M | ﹤0.01% | 1777 |
|
|
2016
Q2 | $3.41M | Sell |
150,234
-163,078
| -52% | -$3.52M | ﹤0.01% | 2716 |
|
|
2016
Q1 | $5.89M | Buy |
313,312
+8,898
| +3% | +$146K | ﹤0.01% | 2309 |
|
|
2015
Q4 | $4.99M | Buy |
304,414
+42,347
| +16% | +$672K | ﹤0.01% | 2463 |
|
|
2015
Q3 | $2.88M | Sell |
262,067
-3,956
| -1% | -$50.4K | ﹤0.01% | 2819 |
|
|
2015
Q2 | $3.46M | Buy |
266,023
+5,297
| +2% | +$82.2K | ﹤0.01% | 2752 |
|
|
2015
Q1 | $4.52M | Buy |
260,726
+12,884
| +5% | +$236K | ﹤0.01% | 2564 |
|
|
2014
Q4 | $3.7M | Sell |
247,842
-17,694
| -7% | -$308K | ﹤0.01% | 2687 |
|
|
2014
Q3 | $6.12M | Buy |
265,536
+152,158
| +134% | +$4.41M | ﹤0.01% | 2382 |
|
|
2014
Q2 | $3.62M | Buy |
+113,378
| New | +$3.41M | ﹤0.01% | 2743 |
|
Other funds holding TBPH
MAP
WAM
NM
ICM
VCM
Northern Trust's TBPH Position: Q1 2026 in Review
Northern Trust increased its Theravance Biopharma (TBPH) stake by 12% in Q1 2026, buying an estimated $718K and bringing the position to 370,534 shares worth $6.01M. The position accounts for ﹤0.01% of the portfolio, ranked #2362.
Northern Trust first reported a position in TBPH in Q2 2014 and has held it in 48 quarters since. The position peaked at $21.1M in Q2 2017. 173 funds tracked by Wall St. Rank hold TBPH as of Q1 2026.
- Northern Trust held 370,534 shares of Theravance Biopharma worth $6.01M as of Q1 2026.
- Northern Trust bought 40,607 Theravance Biopharma shares in Q1 2026, an estimated $718K.
- Theravance Biopharma made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2362 holding.
- Northern Trust first reported a position in Theravance Biopharma in Q2 2014 and has held it in 48 quarters since.
- Northern Trust's Theravance Biopharma position peaked at $21.1M in Q2 2017.
- 173 funds tracked by Wall St. Rank held Theravance Biopharma as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.